DE69525347D1 - Krebsbehandlung mittels humanen choriongonadotropin - Google Patents
Krebsbehandlung mittels humanen choriongonadotropinInfo
- Publication number
- DE69525347D1 DE69525347D1 DE69525347T DE69525347T DE69525347D1 DE 69525347 D1 DE69525347 D1 DE 69525347D1 DE 69525347 T DE69525347 T DE 69525347T DE 69525347 T DE69525347 T DE 69525347T DE 69525347 D1 DE69525347 D1 DE 69525347D1
- Authority
- DE
- Germany
- Prior art keywords
- cancer treatment
- choriongonadotropine
- human
- human choriongonadotropine
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/286,299 US5677275A (en) | 1994-08-05 | 1994-08-05 | Treatment of cancer with human chorionic gonadotropin |
PCT/US1995/009892 WO1996004008A1 (en) | 1994-08-05 | 1995-08-03 | Treatment of cancer with human chorionic gonadotropin |
AU53516/99A AU750123B2 (en) | 1994-08-05 | 1999-10-07 | Treatment of cancer with human chorionic gonadotropin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69525347D1 true DE69525347D1 (de) | 2002-03-21 |
Family
ID=25630094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69525347T Expired - Lifetime DE69525347D1 (de) | 1994-08-05 | 1995-08-03 | Krebsbehandlung mittels humanen choriongonadotropin |
Country Status (7)
Country | Link |
---|---|
US (2) | US5677275A (de) |
EP (1) | EP0774973B1 (de) |
JP (1) | JPH10505588A (de) |
AU (2) | AU3238695A (de) |
CA (1) | CA2196748A1 (de) |
DE (1) | DE69525347D1 (de) |
WO (1) | WO1996004008A1 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5677275A (en) * | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
ATE350052T1 (de) * | 1995-10-16 | 2007-01-15 | Applied Research Systems | Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma |
US5968513A (en) * | 1996-06-24 | 1999-10-19 | University Of Maryland Biotechnology Institute | Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin |
US5997871A (en) * | 1996-06-24 | 1999-12-07 | University Of Maryland Biotechnology Insitute | Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
US6319504B1 (en) * | 1996-06-24 | 2001-11-20 | University Of Maryland Biotechnology Institute | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
IT1284876B1 (it) * | 1996-08-07 | 1998-05-22 | Applied Research Systems | Hcg come inibitore della collagenasi |
US6331610B1 (en) | 1997-04-25 | 2001-12-18 | Metatron, Inc. | Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin |
US6583109B1 (en) | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
US6683050B1 (en) * | 1997-08-01 | 2004-01-27 | Altachem Pharma Ltd. | Compounds with anti-KS and anti-HIV activity |
CN1271365A (zh) * | 1997-08-01 | 2000-10-25 | 阿尔塔切姆法尔马有限公司 | 具有抗-ks和抗hiv活性的化合物 |
US6921751B1 (en) | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
US7175679B2 (en) * | 2001-03-29 | 2007-02-13 | Biotempt B.V. | Oligopeptide treatment of NF-κB mediated inflammation |
US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
EP1138692A1 (de) * | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren |
US20040202645A1 (en) * | 2003-04-08 | 2004-10-14 | Khan Nisar Ahmed | Administration of gene-regulatory peptides |
US20050227925A1 (en) * | 2004-04-08 | 2005-10-13 | Robbert Benner | Compositions capable of reducing elevated blood urea concentration |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US6844315B2 (en) * | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
EP1013281A1 (de) * | 1998-12-15 | 2000-06-28 | Applied Research Systems ARS Holding N.V. | hCG Therapie für Behandlung von Brustkrebs |
US7994278B1 (en) | 1999-08-06 | 2011-08-09 | Nobel Biosciences Llc | Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) |
US6716428B1 (en) * | 1999-10-06 | 2004-04-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US7576174B2 (en) * | 2000-03-29 | 2009-08-18 | Biotempt B.V. | Compositions capable of reducing elevated blood urea concentration |
USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
US20050037430A1 (en) * | 2000-03-29 | 2005-02-17 | Biotempt B.V. | Methods and uses for protein breakdown products |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
EP1300418A1 (de) | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Genregulation durch Oligopeptide |
US20030220259A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of neurological disorders |
WO2003052064A2 (en) * | 2001-12-14 | 2003-06-26 | Centocor Inc. | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
US20030166147A1 (en) * | 2001-12-14 | 2003-09-04 | Lee Chichang | Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
US7501391B2 (en) * | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
US20030220257A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of trauma |
US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US20030224995A1 (en) * | 2001-12-21 | 2003-12-04 | Khan Nisar Ahmed | Treatment of burns |
US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
US20030220260A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Peptide compositions |
US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
US7560433B2 (en) * | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
US20030220261A1 (en) * | 2001-12-21 | 2003-11-27 | Khan Nisar Ahmed | Treatment of iatrogenic disease |
US20040013661A1 (en) * | 2001-12-21 | 2004-01-22 | Gert Wensvoort | Stratification |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
KR20080033331A (ko) * | 2005-07-05 | 2008-04-16 | 바이오템프트, 비.브이. | 종양 치료제 |
WO2007035395A2 (en) * | 2005-09-16 | 2007-03-29 | Virginia Commonwealth University Intellectual Property Foundation | Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors |
EP1864692A1 (de) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Verwendung von peptiden zum Schutz von Strahlenschäden |
DK2120991T3 (da) * | 2007-02-12 | 2014-04-28 | Biotempt Bv | Behandling af traumatisk blødning med korte oligopeptider |
RU2010114012A (ru) * | 2007-09-11 | 2011-10-20 | Мондобайотек Лабораториз Аг (Li) | ПРИМЕНЕНИЕ Tyr-W-Mif-1 И УРОКОРТИНА 2 В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКИХ СРЕДСТВ |
KR20100058554A (ko) * | 2007-09-11 | 2010-06-03 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 망막 콜린성 뉴런을 위한 신경영양성 인자 (nfrcn) 및 융모성 고나도트로핀―베타 (109―145)의 용도 |
EP2109054A1 (de) * | 2008-04-09 | 2009-10-14 | Biotempt B.V. | Verfahren zur Identifizierung biologisch aktiver Peptide und Vorhersage ihrer Funktion |
EP2490021A1 (de) | 2011-02-18 | 2012-08-22 | Biotempt B.V. | Modulatoren von PRR- und GPCR-Signalisierung |
US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
US20150290292A1 (en) | 2012-10-18 | 2015-10-15 | Neuralight Hd, Llc | Treatment of Depression and PTSD |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692332A (en) * | 1985-01-18 | 1987-09-08 | Mcmichael John | Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms |
US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
GB9010058D0 (en) * | 1990-05-04 | 1990-06-27 | Health Lab Service Board | Method and composition for the treatment of cancer |
EP0688432A1 (de) * | 1993-03-11 | 1995-12-27 | Laboratoire L. Lafon | Diagnose sätze für einen hcg oder hcg-fragmente sekretierenden krebs und mittel für die immunotherapie eines solchen krebs |
US5677275A (en) * | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
-
1994
- 1994-08-05 US US08/286,299 patent/US5677275A/en not_active Expired - Lifetime
-
1995
- 1995-08-03 EP EP95928742A patent/EP0774973B1/de not_active Expired - Lifetime
- 1995-08-03 JP JP8506776A patent/JPH10505588A/ja active Pending
- 1995-08-03 WO PCT/US1995/009892 patent/WO1996004008A1/en active IP Right Grant
- 1995-08-03 AU AU32386/95A patent/AU3238695A/en not_active Abandoned
- 1995-08-03 CA CA002196748A patent/CA2196748A1/en not_active Abandoned
- 1995-08-03 DE DE69525347T patent/DE69525347D1/de not_active Expired - Lifetime
-
1997
- 1997-06-06 US US08/869,603 patent/US5877148A/en not_active Expired - Lifetime
-
1999
- 1999-10-07 AU AU53516/99A patent/AU750123B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
US5877148A (en) | 1999-03-02 |
US5677275A (en) | 1997-10-14 |
EP0774973A1 (de) | 1997-05-28 |
EP0774973B1 (de) | 2002-02-06 |
CA2196748A1 (en) | 1996-02-15 |
AU5351699A (en) | 2000-06-08 |
AU3238695A (en) | 1996-03-04 |
WO1996004008A1 (en) | 1996-02-15 |
JPH10505588A (ja) | 1998-06-02 |
AU750123B2 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69525347D1 (de) | Krebsbehandlung mittels humanen choriongonadotropin | |
DE69524138D1 (de) | Hautbehandlungsmittel | |
DE69522448D1 (de) | Gewebebehandlungskassette | |
DE59209614D1 (de) | Elektrochirurgisches Behandlungsinstrument | |
DE69623722T2 (de) | Blutbehandlungsgerät | |
DE69618188D1 (de) | Kosmetisches hautbehandlungsverfahren | |
ATE307601T1 (de) | Brustkrebsbehandlung mittels natürlicher ätherischer öle | |
DE59406123D1 (de) | Haarbehandlungsmittel | |
FR2777466B1 (fr) | Appareil de traitement de tumeur | |
BR9102126A (pt) | Composicao de tratamento de tecido | |
DE59506122D1 (de) | Haut-distraktor | |
BR9101494A (pt) | Tratamento de tecidos | |
ID23528A (id) | Pengobatan terapeutik untuk gangguan kulit | |
DE69528637T2 (de) | Hautbehandlungsmittel gegen akne | |
NO953349D0 (no) | Kombinasjonsterapi av human cancer med cisplatin/tamoxifen | |
DE59301768D1 (de) | Zahnbehandlungseinheit | |
DE69614890D1 (de) | Hautstreckmaschine | |
DE59607418D1 (de) | Haarbehandlungsmittel | |
ATE212858T1 (de) | Krebsbehandlung mittels humanen choriongonadotropin | |
DK0734514T3 (da) | Vævsprøvebehandling | |
KR920000326U (ko) | 두피 마사지기 | |
NO923108D0 (no) | Hudpleie-behandling | |
KR950032248U (ko) | 피부 마사아지기 | |
MD279B1 (ro) | Metoda de terapie tisulara | |
KR960004022U (ko) | 전정기관 치료용 전기 자극기 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |